Published by Josh White on 21st December 2022
(Sharecast News) - Biopharmaceutical company Poolbeg Pharma has successfully identified potential new drug candidates from its respiratory syncytial virus (RSV) artificial intelligence (AI) programme with OneThree Biotech, it announced on Wednesday.
URL: http://www.digitallook.com/dl/news/story/33194015/...